Skip to content
10-Q

Quarterly Report

CTI BIOPHARMA CORP

0000891293-22-000043

← back to feed
Filed
Aug 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 114.39M sh
Shares Diluted Q2 2022 · Jun 30, 2022 108.53M sh
Shares Diluted Q2 2022 · Jun 30, 2022 104.21M sh
Shares Diluted Q2 2022 · Jun 30, 2021 92.34M sh
Shares Diluted Q2 2022 · Jun 30, 2021 84.4M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$50.22M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$34.37M
Long Term Debt Q2 2022 · Jun 30, 2022 $47.66M
Long Term Debt Q2 2022 · Dec 31, 2021 $0
Short Term Debt Q2 2022 · Jun 30, 2022 $0
Short Term Debt Q2 2022 · Dec 31, 2021 $47.38M
Short Term Investments Q2 2022 · Jun 30, 2022 $29.78M
Short Term Investments Q2 2022 · Dec 31, 2021 $0
Cash And Equivalents Q2 2022 · Jun 30, 2022 $66.09M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $65.45M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$5.27M
Stockholders Equity Q2 2022 · Dec 31, 2021 $3.77M
Current Liabilities Q2 2022 · Jun 30, 2022 $29.79M
Current Liabilities Q2 2022 · Dec 31, 2021 $66.65M
Total Liabilities Q2 2022 · Jun 30, 2022 $139.81M
Total Liabilities Q2 2022 · Dec 31, 2021 $68.67M
Current Assets Q2 2022 · Jun 30, 2022 $107.37M
Current Assets Q2 2022 · Dec 31, 2021 $68.38M
Total Assets Q2 2022 · Jun 30, 2022 $134.53M
Total Assets Q2 2022 · Dec 31, 2021 $72.43M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.21
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.57
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.21
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.44
Eps Basic Q2 2022 · Jun 30, 2022 −$0.21
Eps Basic Q2 2022 · Jun 30, 2022 −$0.57
Eps Basic Q2 2022 · Jun 30, 2021 −$0.21
Eps Basic Q2 2022 · Jun 30, 2021 −$0.44
Sga Expense Q2 2022 · Jun 30, 2022 $21.59M
Sga Expense Q2 2022 · Jun 30, 2022 $39.64M
Sga Expense Q2 2022 · Jun 30, 2021 $10.21M
Sga Expense Q2 2022 · Jun 30, 2021 $17.84M
Net Income Q2 2022 · Jun 30, 2022 −$22.65M
Net Income Q2 2022 · Jun 30, 2022 −$59.83M
Net Income Q2 2022 · Mar 31, 2022 −$37.18M
Net Income Q2 2022 · Jun 30, 2021 −$19.68M
Net Income Q2 2022 · Jun 30, 2021 −$36.94M
Net Income Q2 2022 · Mar 31, 2021 −$17.27M
Operating Income Q2 2022 · Jun 30, 2022 −$18.88M
Operating Income Q2 2022 · Jun 30, 2022 −$53.98M
Operating Income Q2 2022 · Jun 30, 2021 −$19.51M
Operating Income Q2 2022 · Jun 30, 2021 −$36.58M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $917K
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.2M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2022 $12.33M
Revenue Q2 2022 · Jun 30, 2022 $14.62M
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $0